| IPO Listing At | NSE SME |
| SME IPO Issue Type | Book Build Issue |
| Total Issue Size | ₹44.68 Cr |
| Reserved for Market Maker | ₹0.00 Cr |
| Net Issue Size | ₹44.68 Cr |
| Fresh Issue | ₹40.31 Cr |
| Offer for Sale | ₹2.12 Cr |
| Face Value | โน10 Per Equity Share |
| Price Band | โน65.00-68.00 per share |
| Discount | Retail: 0.00 |
| NSE Code | DHANSA |
| Registrar | MUFG Intime India Pvt.Ltd. |
| Lead Managers | Novus Capital Advisors Pvt.Ltd. |
Disclaimer: GMP is sourced from grey market dealers and is indicative only. Always conduct your own due diligence.
* Allotment, Refund, Demat Credit & Listing dates are tentative and subject to change.
Minimum bid: 2,000 shares and in multiples thereof
Ambey Laboratories, incorporated in 1985, manufactures agrochemical products for crop protection. The company has been serving the agrochemical sector for almost four decades.
The company manufactures and supplies 2,4-D base chemicals.
The company's manufacturing facility in Behror, Rajasthan, is certified with ISO 9001:2015 by the Quality Research Organization and ISO 14001:2015 by the United Accreditation Foundation.
The company currently produces the following products for its customer base, which includes large corporates like Aromatic Rasayan Private Limited, JR Jindal Infraprojects Private Limited, and SC Formulator Co. Ltd:
ย As of October 31, 2023 the company employs 220 people in various departments.
The Company proposes to utilise the Net Proceeds from the Issue towards the following objects:
| # | Issue Objects | Est Amt (โน Cr.) |
|---|---|---|
| 1 | To meet out the Working Capital requirements | 30.93 |
| 2 | To meet out the General Corporate Purposes | 9.12 |
| 3 | Issue Expenses | 2.50 |
| Period Ended | 31 Jan 2024 | 31 Mar 2023 | 31 Mar 2022 | 31 Mar 2021 |
|---|---|---|---|---|
| Assets | 86.21 | 57.62 | 55.93 | 44.62 |
| Total Income | 100.44 | 107.43 | 85.11 | 82.42 |
| Profit After Tax | 6.08 | 4.57 | 3.57 | 10.34 |
| NET Worth | 34.31 | 23.64 | 19.07 | -7.86 |
| Reserves and Surplus | 15.62 | 5.89 | 1.32 | -12.76 |
| Total Borrowing | 20.05 | 13.65 | 18.05 | 32.93 |
| Amount in ₹ Crore | ||||
| KPI | Jan 31, 2024 |
|---|---|
| ROE | 20.80% |
| ROCE | 13.14% |
| Debt / Equity | 0.58% |
| RoNW | 20.80% |
| PAT Margin | 6.01% |
| Price to Book Value | 3.58 |
| Metric | Pre IPO | Post IPO |
|---|---|---|
| EPS (โน) | 2.44 | 2.89 |
| P/E (x) | 27.81 | 23.54 |
| Promoter Holding | 94.97% | 69.9% |
| Market Cap | โน171.64 Cr. | |